Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration.
Ischemic stroke is the second leading cause of death worldwide. Only one moderately effective therapy exists, albeit with contraindications that exclude 90% of the patients. This medical need contrasts with a high failure rate of more than 1,000 pre-clinical drug candidates for stroke therapies. Thu...
Guardado en:
Autores principales: | Christoph Kleinschnitz, Henrike Grund, Kirstin Wingler, Melanie E Armitage, Emma Jones, Manish Mittal, David Barit, Tobias Schwarz, Christian Geis, Peter Kraft, Konstanze Barthel, Michael K Schuhmann, Alexander M Herrmann, Sven G Meuth, Guido Stoll, Sabine Meurer, Anja Schrewe, Lore Becker, Valérie Gailus-Durner, Helmut Fuchs, Thomas Klopstock, Martin Hrabé de Angelis, Karin Jandeleit-Dahm, Ajay M Shah, Norbert Weissmann, Harald H H W Schmidt |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ca15ac39c2024783aa2cc40faf23366a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Copper oxide-based cathode for direct NADPH regeneration
por: J. T. Kadowaki, et al.
Publicado: (2021) -
The metabolites NADP+ and NADPH are the targets of the circadian protein Nocturnin (Curled)
por: Michael A. Estrella, et al.
Publicado: (2019) -
Effects of Iodonium Analogs on Nadph Oxidase 1 in Human Colon Cancer Cells
por: Krishnendu K. Roy, et al.
Publicado: (2021) -
Neutrophil NET Formation with Microbial Stimuli Requires Late Stage NADPH Oxidase Activity
por: Heather A. Parker, et al.
Publicado: (2021) -
Defective NADPH production in mitochondrial disease complex I causes inflammation and cell death
por: Eduardo Balsa, et al.
Publicado: (2020)